New five-minute Phesgo breast cancer treatment rolled out across NHS

The newly-approved remedy combines two treatments into a single injection, reducing the time needed to administer it by around two and a half hours.

The Phesgo treatment combines two drugs, pertuzumab and trastuzumab, which are usually given separately as two intravenous infusions into a single injection in the thigh.

Peter Johnson, NHS clinical director for cancer, said the treatment would be offered to patients with HER2-positive breast cancer across the country, which will result in around 15% of all breast cancer patients being offered the remedy, either alongside chemotherapy or by itself.

Mr Johnson added that the NHS had “continued to adopt new treatments rapidly throughout the pandemic to improve cancer care for patients” and Phesgo was “the latest in a series of changes which have meant the NHS has been able to deliver vital cancer treatment while keeping patients safe from Covid.”

Chadwick Lawrence’s specialist team of clinical negligence lawyers have years of experience in medical negligence claims, providing support and guidance after life-changing events. Not only do we represent clients in Yorkshire, but because of our reputation we also represent clients nationally.

If you believe that you or a relative may have been injured as a result of clinical/medical negligence, please call for free legal advice from our medical negligence solicitors on the freephone number below.

Posted by Karen Motley, Clinical Negligence Department, Chadwick Lawrence LLP (tonymay@chadlaw.co.uk ), medical negligence lawyers and clinical negligence solicitors in Huddersfield, Leeds, Wakefield and Halifax, West Yorkshire.

Freephone : 0800 304 7382